Annual Cash & Cash Equivalents
$70.91 M
-$12.64 M-15.13%
December 31, 2024
Summary
- As of March 12, 2025, LUNG annual cash & cash equivalents is $70.91 million, with the most recent change of -$12.64 million (-15.13%) on December 31, 2024.
- During the last 3 years, LUNG annual cash & cash equivalents has fallen by -$77.58 million (-52.25%).
- LUNG annual cash & cash equivalents is now -69.38% below its all-time high of $231.56 million, reached on December 31, 2020.
Performance
LUNG Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$70.91 M
+$7.59 M+11.99%
December 1, 2024
Summary
- As of March 12, 2025, LUNG quarterly cash and cash equivalents is $70.91 million, with the most recent change of +$7.59 million (+11.99%) on December 1, 2024.
- Over the past year, LUNG quarterly cash and cash equivalents has increased by +$7.59 million (+11.99%).
- LUNG quarterly cash and cash equivalents is now -69.38% below its all-time high of $231.56 million, reached on December 31, 2020.
Performance
LUNG Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LUNG Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -15.1% | +12.0% |
3 y3 years | -52.3% | +12.0% |
5 y5 years | +380.2% | +12.0% |
LUNG Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -52.3% | at low | -52.3% | +12.0% |
5 y | 5-year | -69.4% | +380.2% | -69.4% | +380.2% |
alltime | all time | -69.4% | +1619.3% | -69.4% | +380.2% |
Pulmonx Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $70.91 M(-15.1%) | - |
Dec 2024 | - | $70.91 M(+12.0%) |
Sep 2024 | - | $63.31 M(-0.2%) |
Jun 2024 | - | $63.46 M(-9.5%) |
Mar 2024 | - | $70.16 M(-16.0%) |
Dec 2023 | $83.55 M(-17.9%) | $83.55 M(-12.0%) |
Sep 2023 | - | $94.94 M(-6.5%) |
Jun 2023 | - | $101.58 M(-8.0%) |
Mar 2023 | - | $110.41 M(+8.5%) |
Dec 2022 | $101.74 M | $101.74 M(-9.5%) |
Sep 2022 | - | $112.40 M(-7.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $121.95 M(-5.6%) |
Mar 2022 | - | $129.17 M(-13.0%) |
Dec 2021 | $148.48 M(-35.9%) | $148.48 M(-21.1%) |
Sep 2021 | - | $188.07 M(-5.3%) |
Jun 2021 | - | $198.70 M(-5.1%) |
Mar 2021 | - | $209.28 M(-9.6%) |
Dec 2020 | $231.56 M(+1468.1%) | $231.56 M(+481.7%) |
Sep 2020 | - | $39.81 M(-8.2%) |
Jun 2020 | - | $43.35 M(+193.5%) |
Dec 2019 | $14.77 M(+258.1%) | $14.77 M |
Dec 2018 | $4.12 M | - |
FAQ
- What is Pulmonx annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Pulmonx?
- What is Pulmonx annual cash & cash equivalents year-on-year change?
- What is Pulmonx quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Pulmonx?
- What is Pulmonx quarterly cash and cash equivalents year-on-year change?
What is Pulmonx annual cash & cash equivalents?
The current annual cash & cash equivalents of LUNG is $70.91 M
What is the all time high annual cash & cash equivalents for Pulmonx?
Pulmonx all-time high annual cash & cash equivalents is $231.56 M
What is Pulmonx annual cash & cash equivalents year-on-year change?
Over the past year, LUNG annual cash & cash equivalents has changed by -$12.64 M (-15.13%)
What is Pulmonx quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LUNG is $70.91 M
What is the all time high quarterly cash and cash equivalents for Pulmonx?
Pulmonx all-time high quarterly cash and cash equivalents is $231.56 M
What is Pulmonx quarterly cash and cash equivalents year-on-year change?
Over the past year, LUNG quarterly cash and cash equivalents has changed by +$7.59 M (+11.99%)